Clinical Trial Update: Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of modified bone marrow stem cell transplantation in HIV-infected patients with hematologic malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hematologic Malignancy

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hematologic Neoplasm, HIV Infection | Phase 1 | Status: COMPLETED